Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.58
-0.03 (-0.53%)
Mar 12, 2025, 1:55 PM EST - Market open
Solid Biosciences Employees
Solid Biosciences had 100 employees as of December 31, 2024. The number of employees increased by 12 or 13.64% compared to the previous year.
Employees
100
Change (1Y)
12
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,246,970
Market Cap
432.41M
Employees Chart
SLDB News
- 5 hours ago - Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewsWire
- 5 days ago - Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 days ago - Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 7 days ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Solid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy Data - Benzinga
- 22 days ago - Solid Biosciences Announces Pricing of Underwritten Offering - GlobeNewsWire
- 22 days ago - Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003 - GlobeNewsWire
- 7 weeks ago - Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart - Seeking Alpha